Screen shot 2015-06-11 at 17.39.07
Latest News
- Zanidatamab approved for NHS use by NICE
- NICE publishes draft recommendation for larotrectinib
- Molecular profiling for patients with Cholangiocarcinoma in Scotland
- The Rare Cancers Act is now law
- Cholangiocarcinoma Awareness Month – February 2026
- The UK Government has published their National Cancer Plan for England
- NICE publishes draft recommendation for zanidatamab
- Biliary tract cancer patient and caregiver experiences survey 2025 report
- A message from Helen Morement, DSc (hc), AMMF’s CEO
- The Scottish Government approve molecular profiling programme for cholangiocarcinoma patients
- AMMF is Shaping the Future for Cholangiocarcinoma in Westminster
- In Memory of James Hastings
- Ivosidenib approved for reimbursement in Ireland
- Scottish Parliament debates cholangiocarcinoma awareness
- Scottish Parliament to debate cholangiocarcinoma awareness
- Jess’s Rule: New Guidance for GPs in England
- Durvalumab approved for reimbursement in Ireland
- CCA-UK – Annual Meeting
- AMMF unites with cancer charities to urge the government to fully fund the National Cancer Plan
- 10 Year Health Plan for England
